BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10786802)

  • 1. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
    Malcolm EK; Baber GB; Boyd JC; Stoler MH
    Mod Pathol; 2000 Apr; 13(4):373-8. PubMed ID: 10786802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
    Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the chinese.
    Wang NM; Tsai CH; Yeh KT; Chen SJ; Chang JG
    Int J Mol Med; 1999 Sep; 4(3):249-52. PubMed ID: 10425273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
    Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 codon 72 polymorphism in breast cancer.
    Buyru N; Tigli H; Dalay N
    Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil.
    Brenna SM; Silva ID; Zeferino LC; Pereira JS; Martinez EZ; Syrjänen KJ
    Gynecol Oncol; 2004 May; 93(2):374-80. PubMed ID: 15099948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
    Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
    Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand.
    Settheetham-Ishida W; Singto Y; Yuenyao P; Tassaneeyakul W; Kanjanavirojkul N; Ishida T
    Cancer Lett; 2004 Jul; 210(2):205-11. PubMed ID: 15183536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
    Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
    Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer.
    Szarka K; Veress G; Kónya J; Gergely L
    Anticancer Res; 1999; 19(3B):2377-9. PubMed ID: 10472360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
    Papadakis EN; Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
    Comar M; Molin GD; Guaschino S; Campello C
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.